Related Experiment Video
Updated: May 15, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Sonic advance: CCN1 regulates sonic hedgehog in pancreatic cancer
1Department of Dentistry, Schulich School of Medicine and Dentistry, Dental Sciences Building, University of Western Ontario, London, ON, Canada, N6A 5C1, Andrew.Leask@schulich.uwo.ca.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is the fifth leading cause of cancer internationally. As the precise molecular pathways that regulate pancreatic cancer are incompletely understood, appropriate targets for drug intervention remain elusive. It is being increasingly appreciated that the cellular microenvironment plays an important role in driving tumor growth and metastasis. CCN1, a member of the CCN family of secreted matricellular proteins, is overexpressed in pancreatic cancer, and may represent a novel target for therapy. Sonic hedgehog (SHh) is responsible for PDAC cell proliferation, epithelial-mesenchymal transition (EMT), maintenance of cancer stemness, migration, invasion, and metastatic growth; in a recent report, it was shown that CCN1 is a potent regulator of SHh expression via Notch-1. CCN1 activity was mediated, at least in part, through altering proteosome activity. These results suggest that CCN1 may be an ideal target for treating PDAC.
Insights
This study identifies CCN1 as a key regulator in pancreatic cancer progression. Targeting CCN1 may offer a novel therapeutic strategy for pancreatic ductal adenocarcinoma (PDAC).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a significant global health challenge.
- Understanding the molecular drivers of PDAC is crucial for developing effective treatments.
- The tumor microenvironment is increasingly recognized for its role in cancer progression.
Purpose of the Study:
- To investigate the role of CCN1 in pancreatic cancer.
- To explore CCN1 as a potential therapeutic target for PDAC.
Main Methods:
- Analysis of CCN1 expression in pancreatic cancer.
- Investigating the regulatory relationship between CCN1, Sonic hedgehog (SHh), and Notch-1 signaling.
- Assessing the impact of CCN1 on proteasome activity.
Main Results:
- CCN1 is overexpressed in pancreatic cancer.
- CCN1 regulates Sonic hedgehog (SHh) expression, influencing PDAC cell proliferation, EMT, stemness, migration, and invasion.
- CCN1's activity is partly mediated by modulating proteasome function.
Conclusions:
- CCN1 plays a critical role in PDAC progression.
- CCN1 represents a promising therapeutic target for pancreatic ductal adenocarcinoma.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

